Literature DB >> 28138992

Long noncoding RNAs (lncRNAs) in triple negative breast cancer.

Qiuhong Wang1, Sheng Gao2, Haibo Li1, Mingming Lv2,3, Cheng Lu2.   

Abstract

Long noncoding RNAs (lncRNAs) are dysregulated in many cancer types, which are believed to play crucial roles in regulating several hallmarks of cancer biology. Triple Negative Breast Cancer (TNBC) is a very aggressive subtype of normal breast cancer, which has features of negativity for ER, PR, and HER2. Great efforts have been made to identify an association between lncRNAs expression profiles and TNBC, and to understand the functional role and molecular mechanism on aberrant-expressed lncRNAs. In this review, we summarized the existed knowledge on the systematics, biology, and function of lncRNAs. The advances from the most recent studies of lncRNAs in the predicament of breast cancer, TNBC, are highlighted, especially the functions of specifically selected lncRNAs. We also discussed the potential value of these lncRNAs in TNBC, providing clues for the diagnosis and treatments of TNBC.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  classification; functions; long noncoding RNAs; triple negative breast cancer

Mesh:

Substances:

Year:  2017        PMID: 28138992     DOI: 10.1002/jcp.25830

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer.

Authors:  Li Xia; Hao Wang
Journal:  Breast J       Date:  2022-05-12       Impact factor: 2.269

Review 2.  Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.

Authors:  Manish K Tripathi; Kyle Doxtater; Fatemeh Keramatnia; Chidi Zacheaus; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2018-04-23       Impact factor: 7.851

Review 3.  Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.

Authors:  Xiangyi Kong; Wenyue Liu; Yanguo Kong
Journal:  J Cell Mol Med       Date:  2017-09-22       Impact factor: 5.310

Review 4.  Long Noncoding RNAs as Biomarkers in Cancer.

Authors:  Luka Bolha; Metka Ravnik-Glavač; Damjan Glavač
Journal:  Dis Markers       Date:  2017-05-29       Impact factor: 3.434

5.  The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.

Authors:  Xi Jin; Xiao-En Xu; Yi-Zhou Jiang; Yi-Rong Liu; Wei Sun; Ya-Jie Guo; Yi-Xing Ren; Wen-Jia Zuo; Xin Hu; Sheng-Lin Huang; Hong-Jie Shen; Fei Lan; Yun-Fei He; Guo-Hong Hu; Gen-Hong Di; Xiang-Huo He; Da-Qiang Li; Suling Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Sci Adv       Date:  2019-03-06       Impact factor: 14.136

6.  A Comparative Study of HOTAIR Expression in Breast Cancer Patient Tissues and Cell Lines.

Authors:  Asghar Arshi; Farzaneh Raeisi; Esmaeil Mahmoudi; Fatemeh Mohajerani; Hamidreza Kabiri; Razieh Fazel; Maedeh Zabihian-Langeroudi; Amela Jusic
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

7.  LINC00511 promotes gastric cancer cell growth by acting as a ceRNA.

Authors:  Chong-Bing Sun; Hong-Yi Wang; Xiao-Qing Han; Yong-Ning Liu; Meng-Chun Wang; Hong-Xia Zhang; You-Feng Gu; Xiao-Gang Leng
Journal:  World J Gastrointest Oncol       Date:  2020-04-15

8.  Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p.

Authors:  Tieying Hou; Long Ye; Shulin Wu
Journal:  Onco Targets Ther       Date:  2021-07-02       Impact factor: 4.147

9.  Robust identification of target genes and outliers in triple-negative breast cancer data.

Authors:  Pieter Segaert; Marta B Lopes; Sandra Casimiro; Susana Vinga; Peter J Rousseeuw
Journal:  Stat Methods Med Res       Date:  2018-08-27       Impact factor: 3.021

Review 10.  The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs.

Authors:  Justin M Brown; Marie-Claire D Wasson; Paola Marcato
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.